日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Reversible downregulation of HLA class I in adenoid cystic carcinoma

腺样囊性癌中HLA I类分子的可逆性下调

Annie Li,Bianca L Gonda,Elizabeth M Codd,Adam von Paternos,Dawn R Mitchell,Markus D Herrmann,Prinjali Kalyan,Samantha E Flynn,Thuc Q Dzu,Chengzhuo Gao,Edwin Zhang,Julia J Mendel,Julia C Thierauf,Peter M Sadow,Thomas Denize,Diane Yang,Florian J Fintelmann,Jo Anne Fordham,Ross D Merkin,Atul K Bhan,Yu-Chung Huang,Jeffrey Raizer,William C Faquin,Daniel L Faden,Xin Gao,Jong Chul Park,Lori J Wirth,Stefan T Kaluziak,A John Iafrate

Immune Cell Densities Predict Response to Immune Checkpoint-Blockade in Head and Neck Cancer

免疫细胞密度可预测头颈癌对免疫检查点阻断的反应

Daniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, Ross D Merkin, Evelyn Luciani, Thomas Roberts, Manisha Patel, Jong C Park, Lori J Wirth, Peter M Sadow, Moshe Sade-Feldman, Shannon L Stott, Daniel L Faden

Effectors Enabling Adaptation to Mitochondrial Complex I Loss in Hürthle Cell Carcinoma

效应因子使嗜酸细胞癌能够适应线粒体复合物 I 的缺失

Raj K Gopal # ,Venkata R Vantaku # ,Apekshya Panda ,Bryn Reimer ,Sneha Rath ,Tsz-Leung To ,Adam S Fisch ,Murat Cetinbas ,Maia Livneh ,Michael J Calcaterra ,Benjamin J Gigliotti ,Kerry A Pierce ,Clary B Clish ,Dora Dias-Santagata ,Peter M Sadow ,Lori J Wirth ,Gilbert H Daniels ,Ruslan I Sadreyev ,Sarah E Calvo ,Sareh Parangi ,Vamsi K Mootha

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

酪氨酸激酶抑制剂 Lenvatinib 通过靶向肿瘤微环境中的周细胞来抑制未分化甲状腺癌的生长

Asumi Iesato, Stephanie Li, Peter M Sadow, Mohammadreza Abbasian, Ara Nazarian, Jack Lawler, Carmelo Nucera

A Comprehensive Study on the Diagnosis and Management of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features

具有乳头状核特征的非侵袭性滤泡性甲状腺肿瘤的诊断和治疗的综合研究

Bayan A Alzumaili, Lauren N Krumeich, Reagan Collins, Timothy Kravchenko, Emad I Ababneh, Adam S Fisch, William C Faquin, Vania Nosé, Maria Martinez-Lage, Gregory W Randolph, Rajshri M Gartland, Carrie C Lubitz, Peter M Sadow

The Tyrosine Kinase Inhibitor Lenvatinib Inhibits Anaplastic Thyroid Carcinoma Growth by Targeting Pericytes in the Tumor Microenvironment

酪氨酸激酶抑制剂乐伐替尼通过靶向肿瘤微环境中的周细胞抑制未分化型甲状腺癌的生长

Asumi Iesato,Stephanie Li,Peter M Sadow,Mohammadreza Abbasian,Ara Nazarian,Jack Lawler,Carmelo Nucera

Cystatin SN is a potent upstream initiator of epithelial-derived type 2 inflammation in chronic rhinosinusitis

胱抑素 SN 是慢性鼻窦炎上皮源性 2 型炎症的强效上游启动因子

Angela L Nocera, Sarina K Mueller, Alan D Workman, Dawei Wu, Kristen McDonnell, Peter M Sadow, Mansoor M Amiji, Benjamin S Bleier

Therapeutic Targeting of the Secreted Lysophospholipase D Autotaxin Suppresses Tuberous Sclerosis Complex-Associated Tumorigenesis

针对分泌型溶血磷脂酶 D 自分泌运动因子的治疗靶向抑制结节性硬化症相关肿瘤发生

You Feng, William J Mischler #, Ashish C Gurung #, Taylor R Kavanagh, Grigoriy Androsov, Peter M Sadow, Zachary T Herbert, Carmen Priolo

Widespread Chromosomal Losses and Mitochondrial DNA Alterations as Genetic Drivers in Hürthle Cell Carcinoma

广泛的染色体丢失和线粒体 DNA 变异是 Hürthle 细胞癌的遗传驱动因素

Raj K Gopal, Kirsten Kübler, Sarah E Calvo, Paz Polak, Dimitri Livitz, Daniel Rosebrock, Peter M Sadow, Braidie Campbell, Samuel E Donovan, Salma Amin, Benjamin J Gigliotti, Zenon Grabarek, Julian M Hess, Chip Stewart, Lior Z Braunstein, Peter F Arndt, Scott Mordecai, Angela R Shih, Frances Chaves, 

[18F]Fluorocholine and [18F]Fluoroacetate PET as Imaging Biomarkers to Assess Phosphatidylcholine and Mitochondrial Metabolism in Preclinical Models of TSC and LAM

[18F]氟胆碱和 [18F]氟乙酸 PET 作为影像生物标记物用于评估 TSC 和 LAM 临床前模型中的磷脂酰胆碱和线粒体代谢

Eline E Verwer, Taylor R Kavanagh #, William J Mischler #, You Feng, Kazue Takahashi, Shuyan Wang, Timothy M Shoup, Ramesh Neelamegam, Jing Yang, Nicolas J Guehl, Chongzhao Ran, Walter Massefski, Ye Cui, Souheil El-Chemaly, Peter M Sadow, William M Oldham, Marie F Kijewski, Georges El Fakhri, Marc D